A polymorphism (A118G) in the μ-opioid receptor gene affects the response to morphine-6-glucuronide in humans

This publication has 10 references indexed in Scilit:

• The polymorphism A118G of the human mu-opioid receptor gene decreases the pupil constrictory effect of morphine-6-glucuronide but not that of morphine
  Pharmacogenetics, 2002
• Regulation of μ-Opioid Receptor Gene Transcription by Interleukin-4 and Influence of an Allelic Variation within a STAT6 Transcription Factor Binding Site
  Published by Elsevier ,2001
• Incomplete cross tolerance and multiple mu opioid peptide receptors
  Trends in Pharmacological Sciences, 2001
• A Single Nucleotide Polymorphic Mutation in the Human μ-Opioid Receptor Severely Impairs Receptor Signaling
  Published by Elsevier ,2001
• Nonreplication of association between ?-opioid-receptor gene (OPRM1) A118G polymorphism and substance dependence
  American Journal of Medical Genetics, 2001
• Opioid receptor and peptide gene polymorphisms: potential implications for addictions
  European Journal of Pharmacology, 2000
• Sequence variability and candidate gene analysis in complex disease: association of micro opioid receptor gene variation with substance dependence
  Human Molecular Genetics, 2000
• Allelic Variation S268P of the Human μ-Opioid Receptor Affects Both Desensitization and G Protein Coupling
  Molecular Pharmacology, 2000
• Single-nucleotide polymorphism in the human mu opioid receptor gene alters β-endorphin binding and activity: Possible implications for opiate addiction
  Proceedings of the National Academy of Sciences, 1998
• Hydroxylation polymorphisms of debrisoquine and mephenytoin in European populations
  European Journal of Clinical Pharmacology, 1990